Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-016927
Filing Date
2022-03-08
Accepted
2022-03-08 11:33:56
Documents
2
Period of Report
2022-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1636
2 POA DOCUMENT poa.txt EX-24 3585
  Complete submission text file 0001209191-22-016927.txt   6660
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
Friedl-Naderer Johanna (Reporting) CIK: 0001915598 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39083 | Film No.: 22720822